Will you have Umbilical granuloma with Mexiletine hydrochloride - from FDA reports


There is no Umbilical granuloma reported by people who take Mexiletine hydrochloride yet. This review analyzes which people have Umbilical granuloma with Mexiletine hydrochloride. It is created by eHealthMe based on reports from FDA, and is updated regularly.

What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on mexiletine hydrochloride (the active ingredients of Mexiletine hydrochloride) and Mexiletine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Umbilical granuloma are also considered in the study.

What is Mexiletine Hydrochloride?

Mexiletine hydrochloride has active ingredients of mexiletine hydrochloride. (latest outcomes from Mexiletine hydrochloride 584 users)

What is Umbilical Granuloma?

Umbilical granuloma (umbilical abnormality in neonates, causing inflammation and drainage) has been reported by people with epilepsy, fever, hypersensitivity, hypothyroidism, high blood pressure (latest reports from 19 Umbilical granuloma patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.

On Mar, 22, 2019

No report is found.

Do you have Umbilical granuloma while taking Mexiletine hydrochloride?

You are not alone:

Related studies

Drugs that are associated with Umbilical granuloma
Umbilical granuloma
Could your condition cause Umbilical granuloma
Umbilical granuloma
Mexiletine hydrochloride side effects

Browse by age

0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mexiletine hydrochloride
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Mexiletine hydrochloride and have Umbilical granuloma

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.